Autonomy Powers Award-Winning Website for Leading Swiss Pharmaceutical Company

Autonomy Corporation plc (LSE: AU. or AU.L), a global leader in infrastructure software for the enterprise, today announced that the website of leading Swiss pharmaceutical company Actelion, powered by Autonomy's flagship Web Content Management (WCM) platform, has twice consecutively been named the winner of the Swiss Pharma Site Monitor performance report. The Swiss Pharma Site Monitor report, which provides a unique combination of insights on key competences, ranging from web diagnostic reporting and usability to online strategy and management, cites Actelion's Headquartered in Switzerland, Actelion is a biopharmaceutical company focusing on the discovery, development and commercialization of innovative treatments to serve high, unmet medical needs. Actelion has subsidiaries in 29 countries, covering all major pharmaceutical markets worldwide. The company leverages Autonomy's meaning-based WCM solution to effectively manage and optimize web content segmentation and delivery in order to meet the customer experience needs of its diverse target groups.Powered by the Intelligent Data Operating Layer (IDOL), Autonomy WCM is the industry's only solution to leverage pattern-based technology to form, in real-time, a conceptual and contextual understanding of all customer interactions from multiple channels, and enable the automatic delivery of optimized online content. Autonomy TeamSite allows Actelion employees to create and deliver the content on its website from an intuitive, unified interface, while Autonomy LiveSite enables the creation of dynamic, interactive and targeted sites for any purpose, such as a special corporate announcement. By enabling Actelion employees to easily create and dynamically deliver highly-targeted, consistent, and engaging web content, Autonomy's WCM solution was able to seamlessly support a comprehensive creative re-design of the Actelion website in early 2011.The Swiss Pharma Site Monitor utilizes an objective, state-of-the-art benchmarking system that weighs all criteria relevant for the success of a website, which it divides into the three main areas of 'quality', 'usability', and 'business value'. "Since the implementation of Autonomy's WCM platform, Actelion's website has been awarded the highest ranking by the Swiss Pharma Site Monitor twice in a row. It has also undergone comprehensive creative redesign," commented Actelion. "Autonomy WCM has had a pivotal role in making this a reality by giving us a powerful, intelligent and easy-to-use online marketing platform for managing our strategic initiatives and significantly reducing time to web.""As the industry's most integrated and comprehensive solution, Autonomy WCM enjoys a track record of powering over 20,000 websites worldwide, including those of some of the largest global brands," said James Murray, VP Autonomy Promote Solutions EMEA. "The fact that one of these websites, Actelion, has twice been independently recognized for its excellence is a further testament to the concrete benefits of the Autonomy solution."As a future extension to its longstanding partnership with Autonomy, Actelion plans to adopt more of Autonomy's meaning-based platform for enterprise search and analytics, also powered by IDOL, to penetrate all information silos, derive maximum value from corporate assets, and boost employee productivity, while minimizing the risks endemic to information proliferation.